08 September 2022

The immune cells of patients who received hospital care for COVID-19 early in the pandemic were still affected six months later. A new study suggests that infection by the SARS-CoV-2 virus leaves significant effects long after the patient is symptom-free. The results have been published in Frontiers in Immunology.

Cell culture plate with brown spots.Assay of T cells that recognise the corona virus and can fight the infection. Each spot marks the reaction from a T cell to SARS-COV-2. Photo credit Magnus Johansson

“We see that severe COVID-19 infection has long-lasting negative effects on the immune system. Obviously, the immune system is affected pretty badly when people are in hospital sick with COVID, but we had not anticipated that the effects would persist as long as 7-8 months later,” says Francis Hopkins, postdoc in the Department of Biomedical and Clinical Sciences at Linköping University.Francis Hopkins.Francis Hopkins. Photo credit Magnus Johansson

Several types of cells are important when the immune system starts to combat the SARS-CoV-2 virus. Some white blood cells, B cells, form antibodies that recognise and bind to particular parts of the virus, while several types of T cells help to kill infected cells. In the current study, researchers at Linköping University have looked at whether a severe COVID-19 infection has long-term effects on the body’s immune cells.

They looked at 46 patients with COVID-19 who had received care at Vrinnevi Hospital in Norrköping, and 31 healthy control subjects. The researchers analysed blood samples taken from the patients when admitted to hospital, and taken 2 weeks, 6 weeks and 6-8 months later. They not only looked at the properties of the virus-specific T cells, but also examined whether the disease had had a general effect on all T cells.Marie Larsson.Professor Marie Larsson. Photo credit Magnus Johansson

“The effects on the T cells of the immune system are interesting and mixed. Some of them are still activated long after the disease episode, while others are ‘fatigued’ and cannot function normally. We see similar effects on patients with a chronic HIV infection. The question is: why are these effects still present after so long?” asks Marie Larsson, professor of virology at the Department of Biomedical and Clinical Sciences at Linköping University, and leader of the study.

In the early phase of the pandemic, scientists at LiU helped to develop tests that the healthcare system could use to analyse patient samples. At this early stage, it was not known whether different people's immune systems differed in their ability to form antibodies against the virus. If so, would this affect the severity of the disease? What the current study showed was that all patients developed antibodies against the virus within 2-3 weeks of first showing symptoms, which has been shown also by several previous studies. Melissa Govender.Melissa Govender. Photo credit Magnus Johansson

“We see that all the patients in the study developed antibodies against SARS-CoV-2. The levels of these antibodies started to fall after six months,” says Melissa Govender, postdoc in the group.

The study has received funding from SciLifeLab/KAW COVID-19 and the Swedish Research Council, with ALF funds from Region Östergötland and Linköping University.

The article: T cell perturbations persist for at least 6 months following hospitalization for COVID-19, Melissa Govender, Francis Hopkins, Robin Göransson, Cecilia Svanberg, Esaki Shankar, Maria Hjorth, Åsa Nilsdotter-Augustinsson, Johanna Sjöwall, Sofia Nyström and Marie Larsson, (2022), Frontiers in Immunology, published online 8 August 2022, DOI:10.3389/fimmu.2022.931039

Translated by George Farrants

More research on covid-19

Latest news from LiU

Iontronic pump in thin blood vessels.

More effective cancer treatment with iontronic pump

When low doses of cancer drugs are administered continuously near malignant brain tumours using so-called iontronic technology, cancer cell growth drastically decreases. This is demonstrated in experiments with bird embryos.

Electronic medicine – at the intersection of technology and medicine

Swedish researchers have developed a gel that can form a soft electrode capable of conducting electricity. In the long term, they aim to connect electronics to biological tissue, such as the brain.

Green lights on the backside of a supercomputer.

Agreement signed – supercomputer Arrhenius to Linköping

The hosting agreement between NAISS at LiU and EuroHPC JU has been signed. This means that LiU is now officially hosting the European supercomputer Arrhenius, which will become one of the world’s fastest computers.